Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
ConAgra Foods Inc. (CAG - Analyst Report) reported upbeat financial results for the fiscal first quarter 2013 (ended August 26, 2012). Earnings per share from continuing operations were 61 cents as against 22 cents reported in the year-ago quarter.
However, diluted earnings per share from continuing operations, adjusted for items impacting comparability, was recorded at 44 cents versus 31 cents reported in the year-ago quarter. Results surpassed the Zacks Consensus Estimate of 36 cents.
Revenues
Net sales improved 6.7% to $3,311.9 million from $3,105.3 million in the year-earlier quarter, driven by improved pricing, moderating inflation and contribution from acquired businesses. Reported revenue was above the Zacks Consensus Estimate of $3,234 million.
On a segmental basis, Commercial Foods surged 4.6% year over year to $1,269.3 million, led by the benefit of favorable price-mix and healthy growth in the Lamb Weston potato operations. Revenues from the Consumer Food segment rose 8.0% to $2,042.6 million during the quarter. The rise reflects contribution from favorable acquisitions and price/mix.
Margins
In the reported quarter, cost of goods sold (COGS) inched down 2.7% from the year-earlier quarter to $2,440.6 million. SG&A (selling, general and administrative) expense was $453.9 million, up 11.6% year over year. Net interest expense was recorded at $49.3 million, down 6.8% year over year. Operating margin was recorded at 11.1% as against 4.4% during the year-earlier quarter.
Balance Sheet/Cash Flow
Cash and cash equivalents at end of fiscal first quarter 2013 were $116.5 million, an increase from $103.0 million in the previous quarter. Senior long-term debt remained roughly flat to $2,663.8 million sequentially .
Net cash flow from operating activities in the reported period was $323.9 million as against $315.1 million generated in the year-ago comparable quarter. Capital spending was up 3.1% to $98.6 million.
During the quarter, the company paid dividends amounting to $97.9 million and repurchased 2.95 million shares worth $75 million. Roughly $450 million share repurchase authorization was available for the company.
Management also announced that they have received the Board of Directors’ approval for an increase of a cent in quarterly dividend rate to 25 cents. Revised annualized dividend rate now stands at $1.00 per share. The new dividend will be paid on December 4, 2012 to shareholders of record as of October 31, 2012.
Guidance
For fiscal 2013, ConAgra revised its earnings per share (adjusted for items impacting comparability) guidance range to $2.03-$2.06. Marketing expenses in the year are expected to get a boost versus fiscal 2012. Tax rate is anticipated to be roughly 34% for the year. Operating cash flow is expected to be over $1.2 billion.
Get the full Analyst Report on CAG - FREE